Fregene T, Kellogg C, Pienta K
UNIV MICHIGAN,DIV HEMATOL & ONCOL,ANN ARBOR,MI 48109. WAYNE STATE UNIV,DIV HEMATOL & ONCOL,DETROIT,MI 48202.
Oncol Rep. 1995 Nov;2(6):1181-4. doi: 10.3892/or.2.6.1181.
Neovascularization is a key step in the transformation of normal breast tissue into a cancerous phenotype. We investigated the angiogenic activity of 58 cases of histologically confirmed benign breast lesions quantitating angiogenic activity by factor VIII highlighting of endothelial cells. The mean microvessel count (MVC) for all patients was 51 per 0.19 mm(2) in the area of highest angiogenic activity at x400 magnification (range 21-113 per mm(2)). MVC in benign tissues were similar to those found previously in cancer tissues. These data suggest that the 'angiogenic switch' occurs early in breast transformation and that a role may exist for the use of MVC in the identification of persons at heightened risk for subsequent development of breast cancer.
新生血管形成是正常乳腺组织转变为癌性表型的关键步骤。我们通过内皮细胞的因子VIII染色来定量血管生成活性,研究了58例经组织学证实的良性乳腺病变的血管生成活性。在400倍放大倍数下,所有患者在血管生成活性最高区域的平均微血管计数(MVC)为每0.19平方毫米51个(范围为每平方毫米21 - 113个)。良性组织中的MVC与先前在癌组织中发现的相似。这些数据表明,“血管生成开关”在乳腺转变的早期就已发生,并且MVC在识别后续患乳腺癌风险增加的人群中可能具有作用。